We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Product Safety Report for Uniparco Pure White Cosmetics Gold Glowing presenting a serious chemical risk.
Product Safety Report for Gandour Light & Natural Carotone Skin Lightening Cream presenting a serious chemical risk.
Product Safety Report for Kojic Clear lotion with Papaya presenting a chemical risk.
Product Safety Report for Irodis B.B. Clear Skin Lightening Cream presenting a serious chemical risk.
Product Safety Report for Wau Wa Eczema Herbal Cream presenting a serious chemical risk.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
Product Safety Report for CT Cosmetics Extra Pure White Gold Glowing, B.S.C. Black Spot Corrector presenting a serious chemical risk.
Product Safety Report for Skin Gard Lightening Lotion presenting a serious chemical risk.
Product Safety Report for Kojic Clear Cream with Lemon presenting a serious chemical risk.
Product Safety Report for Stay Young Face & Body Cream sold via eBay presenting a serious chemical risk.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Product Safety Report for Dermiron-Plus Cream presenting a serious chemical risk.
We are considering making Dovonex Psoriasis 50 microgram/g Ointment available to buy from pharmacies. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about this change.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the medicine piflufolastat (18F) (Pylclari) as a diagnostic tool for people with suspected or known prostate cancer.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (27 December) approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of 12.
There have been a small number of reports of serious and life-threatening anticholinergic side effects associated with hyoscine hydrobromide patches, particularly when used outside the licence. Healthcare professionals, patients, parents and carers should be aware of the signs and symptoms...
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Decision on application for authorisation under UK REACH.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).